feed,title,long_url,short_url
Benzinga,ChemoCentryx Stock Plunges As FDA Briefing Document Casts Doubt On Vasculitis Candidate Avacopan's Data,https://benzinga.com/general/biotech/21/05/20945235/chemocentryx-stock-plunges-as-fda-briefing-document-casts-doubt-on-vasculitis-candidate-avacopans,https://j.mp/3eSqPCO
Benzinga,When Will The Selling Pressure In These 2 Hot Stocks End?,https://benzinga.com/markets/penny-stocks/21/05/20935690/when-will-the-selling-pressure-in-these-2-hot-stocks-end,https://j.mp/3eRtrkb
